Category: Health
The FDA has approved a new painkiller called Journavx, developed by Vertex Pharmaceuticals, which aims to relieve post-surgical pain without the addictive qualities of opioids. This novel sodium channel blocker works by preventing pain signals from reaching the brain, marking a significant advancement in pain management.
Keywords: painkiller, Journavx, opioid alternatives
Update At: 2/1/2025